EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Subfoveal neovascularization in the ocular histoplasmosis syndrome. A natural history study






Retina 8(4): 225-229

Subfoveal neovascularization in the ocular histoplasmosis syndrome. A natural history study

The visual outcome of 74 eyes with the ocular histoplasmosis syndrome and active subfoveal subretinal neovascular membranes was studied retrospectively. Follow-up time ranged from 12 to 109 months (median, 36.5 months). Ten eyes (14%) retained visual acuity of 20/40 or better. Fifty-seven eyes (77%) suffered visual loss of 20/100 or worse and 36 eyes (49%) suffered visual loss of 20/400 or worse.


Accession: 001959391

PMID: 2466316



Related references

Thomas, M.A.; Kaplan, H.J., 1991: Surgical removal of subfoveal neovascularization in the presumed ocular histoplasmosis syndrome. We treated two patients with presumed ocular histoplasmosis, subfoveal neovascular membranes, and progressive visual acuity loss to 20/400. Vitreoretinal surgical techniques were used to remove the subfoveal membranes. Visual acuity returned to 20...

Meyer, D.; Linn, J.; Blinder, K.; Xu, S.; Go, R., 1998: Surgical removal of subfoveal choroidal neovascularization in presumed ocular histoplasmosis syndrome. IOVS 39(4): S602, March 15

Melberg, N.S.; Thomas, M.A.; Dickinson, J.D.; Valluri, S., 1996: Managing recurrent neovascularization after subfoveal surgery in presumed ocular histoplasmosis syndrome. Purpose: To report the authors' experience with recurrent neovascularization after subfoveal surgery in the presumed ocular histoplasmosis syndrome (POHS). Methods: One-hundred seventeen patients with POHS and subfoveal choroidal neovasculari...

Olk, R.J.; Burgess, D.B.; McCormick, P.A., 1984: Subfoveal and juxtafoveal subretinal neovascularization in the presumed ocular histoplasmosis syndrome. Visual prognosis. The visual prognosis of 148 eyes in patients with an active subfoveal or juxtafoveal subretinal neovascular membrane (SRNVM) in the presumed ocular histoplasmosis syndrome (POHS) was reviewed. Average follow-up was 39 months. One hundred twenty of...

Liu, J.C.; Boldt, H.Culver.; Folk, J.C.; Gehrs, K.M., 2004: Photodynamic therapy of subfoveal and juxtafoveal choroidal neovascularization in ocular histoplasmosis syndrome: a retrospective case series. Purpose: To evaluate the safety and effect on visual acuity of photodynamic therapy (PDT) with verteporfin in patients with subfoveal and juxtafoveal choroidal neovascular membranes from ocular: histoplasmosis syndrome (OHS). Methods: Retrospectiv...

Postelmans, L.; Pasteels, B.; Coquelet, P.; Caspers, L.; Verougstraete, C.; Leys, A.; Wirix, M.; Mauget-Faÿsse, M.; Quanranta, M.; Snyers, B.; Smets, E., 2006: Photodynamic therapy for subfoveal classic choroidal neovascularization related to punctate inner choroidopathy (PIC) or presumed ocular histoplasmosis-like syndrome (POHS-like). To evaluate the safety and efficacy of photodynamic therapy with verteporfin (PDT) for subfoveal classic choroidal neovascularization (CNV) related to punctate inner choroidopathy (PIC) or presumed ocular histoplasmosis-like syndrome (POHS-like)....

Postelmans, L.; Pasteels, B.; Coquelet, P.; Caspers, L.; Verougstraete, C.; Leys, A.; Wirix, M.; Mauget Faysse, M.; Quaranta, M.; Rolland, F.; Snyers, B.; Smets, E., 2005: Photodynamic therapy for subfoveal classic choroidal neovascularization related to punctate inner choroidopathy (PIC) or presumed ocular histoplasmosis-like syndrome (POHS-like). Purpose: To evaluate the safety and efficacy of photodynamic therapy with verteporfin (PDT) for subfoveal classic choroidal neovascularization (CNV) related to punctate inner choroidopathy (PIC) or presumed ocular histoplasmosis-like syndrome (POH...

Saperstein, D.A.; Rosenfeld, P.J.; Bressler, N.M.; Rosa, R.H.Jr; Sickenberg, M.; Sternberg, P., J.; Aaberg, T.M.Sr; Aaberg, T.M.Jr; Reaves, T.A., 2002: Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: One-year results of an uncontrolled, prospective case series. Objective: To evaluate the safety and effect on visual acuity of photodynamic therapy with verteporfin (Visudyne, Novartis AG) in patients with subfoveal choroidal neovascularization (CNV) secondary to the ocular histoplasmosis syndrome (OHS). Des...

Saperstein, D.A.; Rosenfeld, P.J.; Bressler, N.M.; Rosa, R.H.; Sickenberg, M.; Sternberg, P.; Aaberg, T.M.; Aaberg, T.M.; Reaves, T.A., 2002: Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series. To evaluate the safety and effect on visual acuity of photodynamic therapy with verteporfin (Visudyne, Novartis AG) in patients with subfoveal choroidal neovascularization (CNV) secondary to the ocular histoplasmosis syndrome (OHS). Open-label, th...

Bass, E.B.; Gilson, M.M.; Mangione, C.M.; Hawkins, B.S.; Miskala, Päivi.H.; Mann, A.L.; Bressler, N.M., 2008: Surgical removal vs observation for idiopathic or ocular histoplasmosis syndrome-associated subfoveal choroidal neovascularization: Vision Preference Value Scale findings from the randomized SST Group H Trial: SST Report No. 17. Objective: To determine whether patients receiving observation vs surgery for subfoveal choroidal neovascularization that was idiopathic or associated with histoplasmosis differed in preference values assigned to their health and vision status. Me...